Clincosm LogoSign in Get a demo

pancreatic cancer

Showing NaN - NaN of 104
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

Recruiting
  • Gynecologic Cancer
  • +11 more
  • Neoantigen specific TCR-T cell drug product
  • Aldesleukin (IL-2)
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022

Solid Tumor, Microsatellite Instability-High (MSI-H) Solid Tumors, Cutaneous Melanoma Trial in Worldwide (LY3300054,

Active, not recruiting
  • Solid Tumor
  • +4 more
  • Nashville, Tennessee
  • +14 more
Jul 21, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Grand Rapids, Michigan
  • +2 more
Jul 18, 2022

Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,

Recruiting
  • Advanced Malignant Neoplasm
  • +5 more
  • AMXI-5001:Dose Escalation Phase I
  • AMXI-5001:Dose Expansion Phase II
  • Phoenix, Arizona
  • +7 more
Jul 18, 2022

Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,

Recruiting
  • Any Advanced Solid Tumors
  • +6 more
  • Tampa, Florida
  • +7 more
Jul 13, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Pancreatic Cancer Trial in Houston (MRx0518, Hypofractionated Preoperative Radiation)

Active, not recruiting
  • Pancreatic Cancer
  • MRx0518
  • Hypofractionated Preoperative Radiation
  • Houston, Texas
    MD Anderson Cancer Center
Jul 5, 2022

Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

Active, not recruiting
  • Breast Cancer
  • +10 more
  • Los Angeles, California
  • +7 more
Jun 21, 2022

Tumors, Ovarian Cancer, Breast Cancer Trial in Houston (ZN-c3, Bevacizumab, Pembrolizumab)

Not yet recruiting
  • Tumors
  • +4 more
  • Houston, Texas
    MD Anderson Cancer Center
Jun 20, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Gilbert, Arizona
  • +4 more
Jun 21, 2022

Liver Malignant Tumors, Cholangiocarcinoma Metastatic, Pancreatic Cancer Trial in Houston (high dose rate brachytherapy)

Recruiting
  • Liver Malignant Tumors
  • +3 more
  • high dose rate brachytherapy
  • Houston, Texas
    M D Anderson Cancer Center
Apr 25, 2022

Metastatic Cancer, Solid Tumor, Cholangiocarcinoma Trial in United States (LYT-200, Anti-PD-1, Gemcitabine/nab-paclitaxel)

Recruiting
  • Metastatic Cancer
  • +4 more
  • Phoenix, Arizona
  • +15 more
Mar 9, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
Has Results
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Pancreatic Cancer Trial in Houston (multiTAA specific T cells)

Active, not recruiting
  • Pancreatic Cancer
  • multiTAA specific T cells
  • Houston, Texas
  • +2 more
Feb 7, 2022

HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

Recruiting
  • HER2-positive
  • +30 more
  • CT-0508
  • Duarte, California
  • +4 more
Feb 1, 2022

Pancreatic Cancer Trial in Belgium, Singapore, United States (Avelumab, Binimetinib, Talazoparib)

Terminated
Has Results
  • Pancreatic Cancer
  • Fayetteville, Arkansas
  • +17 more
Dec 28, 2021

Pancreatic Cancer, Stereotactic Body Radiation Therapy Trial in United States (Avasopasem (GC4419), Placebo, Stereotactic

Completed
  • Pancreatic Cancer
  • Stereotactic Body Radiation Therapy
  • Avasopasem (GC4419)
  • +2 more
  • Tampa, Florida
  • +5 more
Jan 6, 2022

Oncology, Breast Cancer, Prostate Cancer Trial in Worldwide (Radiation therapy)

Recruiting
  • Oncology
  • +37 more
  • Radiation therapy
  • Houston, Texas
  • +7 more
Aug 23, 2021

Metastatic Pancreatic Cancer, Pancreatic Cancer Trial in Worldwide (IMMU-107, , Gemcitabine)

Terminated
  • Metastatic Pancreatic Cancer
  • Pancreatic Cancer
  • Gilbert, Arizona
  • +64 more
Aug 12, 2021

Pancreatic Cancer Trial in United States (Pembrolizumab, Neoadjuvant Chemoradiation)

Recruiting
  • Pancreatic Cancer
  • Phoenix, Arizona
  • +5 more
Aug 11, 2021

Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Trial in Israel, United States (siG12D-LODER, Gemcitabine+nab-Paclitaxel,

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Pancreatic Cancer
  • Hackensack, New Jersey
  • +8 more
Jun 30, 2021

Pancreatic Cancer Trial in Detroit, Houston (genistein, erlotinib HCl, gemcitabine HCl)

Completed
Has Results
  • Pancreatic Cancer
  • genistein
  • +2 more
  • Detroit, Michigan
  • +1 more
Feb 25, 2021

Radiation Exposure To Patients During Endoscopic Retrograde

Recruiting
  • Pancreatic Cancer
  • Endoscopic retrograde cholangiopancreatography - No Intervention have been used other than standard of care
  • Houston, Texas
    Memorial Hermann Hospital
Jan 11, 2021

Pancreatic Cancer Trial in Houston (Gemcitabine)

Terminated
Has Results
  • Pancreatic Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 15, 2020